X0306 4 2016-09-26 0 0001493712 Cell MedX Corp. CMXC 0001626659 HARGREAVES BRADLEY S 904 - 1616 BAYSHORE DRIVE VANCOUVER A1 V6G 3L1 BRITISH COLUMBIA, CANADA 1 1 1 0 VP, Technology and Operations Stock Options (Right to Buy) 0.05 2016-09-26 4 J 0 1250000 0 D Common Stock 1250000 0 D Stock Options (Right to Buy) 0.05 2016-09-26 4 J 0 1250000 0 D Common Stock 1250000 0 D Stock Options (Right to Buy) 0.05 2016-09-26 4 J 0 1250000 0 D Common Stock 1250000 0 D Stock Options (Right to Buy) 0.05 2016-09-26 4 J 0 2500000 0 D Common Stock 2500000 0 D Stock Options (Right to Buy) 0.05 2016-09-26 4 J 0 2500000 0 D Common Stock 2500000 0 D The Options were to vest upon the completion of first clinical trial and delivery of final white paper for the first clinical trial. The Options were to vest upon the design and commencement of the second clinical trial. The Options were to vest upon the completion of second clinical trial and delivery of final white paper for the second clinical trial. The Options were to vest upon the design and commencement of the third clinical trial. The Options were to vest upon the completion of the third clinical trial and delivery of final white paper for the third clinical trial. Options that would have vested were to expire 5 years after vesting. Options that have not vested would have expired on 12/31/2019. Disposition is associated with the cancellation of the unvested portion of the options originally granted to Mr. Hargreaves by the Issuer pursuant to the Option Agreement between the Company and Mr. Hargreaves dated for reference November 25, 2014 Bradley S. Hargreaves 2018-08-24